{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:23:07Z","timestamp":1791256987009,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease of the elderly associated with considerable morbidity and mortality. As unspecific immunosuppressants are still the mainstay of BP therapy, several animal models, based on the passive transfer of autoantibodies or immune cells, have been developed to obtain a better understanding of the pathogenesis of BP and evaluate novel therapeutic interventions. We describe in this study an experimental model inducing BP by immunization of immunocompetent mice with a recombinant form of the immunodominant 15th noncollagenous domain of murine BP180 (type XVII collagen). The homologous noncollagenous 16A domain of human BP180 has previously been identified as an immunodominant region in human BP. Immunization of female SJL\/J mice with the murine peptide led to clinical disease within 14 wk in 56% of mice. In contrast, none of the other strains developed blisters despite the presence of autoantibodies. The clinical disease manifested for at least 8 wk without further manipulation. This novel immunization-induced model reflects key immunopathological characteristics of human BP, including binding of complement-fixing autoantibodies along the dermal\u2013epidermal junction, elevated total IgE serum levels, and infiltration of skin lesions with eosinophilic granulocytes. The use of immunocompetent mice and the induction of sustained clinical disease not requiring additional interventions make this immunization-induced mouse model most suitable to further explore the pathogenesis of BP and novel therapeutic interventions for this and other autoantibody-mediated diseases.<\/jats:p>","DOI":"10.4049\/jimmunol.1100596","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T19:17:02Z","timestamp":1309029422000},"page":"1176-1183","source":"Crossref","is-referenced-by-count":72,"title":["Repetitive Immunization Breaks Tolerance to Type XVII Collagen and Leads to Bullous Pemphigoid in Mice"],"prefix":"10.1093","volume":"187","author":[{"given":"Misa","family":"Hirose","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of L\u00fcbeck , L\u00fcbeck D-23538 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Recke","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of L\u00fcbeck , L\u00fcbeck D-23538 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Beckmann","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of L\u00fcbeck , L\u00fcbeck D-23538 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keio University School of Medicine , Tokyo 108-8345 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ishiko","sequence":"additional","affiliation":[{"name":"First Department of Dermatology, School of Medicine, Faculty of Medicine, Toho University , Tokyo 143-8540 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Bieber","sequence":"additional","affiliation":[{"name":"Institute of Anatomy, University of L\u00fcbeck , L\u00fcbeck D-23538 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Westermann","sequence":"additional","affiliation":[{"name":"Institute of Anatomy, University of L\u00fcbeck , L\u00fcbeck D-23538 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of L\u00fcbeck , L\u00fcbeck D-23538 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of L\u00fcbeck , L\u00fcbeck D-23538 ,","place":["Germany"]},{"name":"Comprehensive Center for Inflammation Medicine, University of L\u00fcbeck , L\u00fcbeck D-23538 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J","family":"Ludwig","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of L\u00fcbeck , L\u00fcbeck D-23538 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,8,1]]},"reference":[{"key":"2025032410232519200_r1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(99)03007-X","article-title":"Pemphigus and bullous pemphigoid","volume":"354","author":"Nousari","year":"1999","journal-title":"Lancet"},{"key":"2025032410232519200_r2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yadr.2007.07.013","article-title":"Bullous pemphigoid: physiopathology, clinical features and management","volume":"23","author":"Di Zenzo","year":"2007","journal-title":"Adv. Dermatol."},{"key":"2025032410232519200_r3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1346-8138.2009.00792.x","article-title":"What\u2019s new in bullous pemphigoid","volume":"37","author":"Ujiie","year":"2010","journal-title":"J. Dermatol."},{"key":"2025032410232519200_r4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0092-8674(81)90115-X","article-title":"Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia","volume":"24","author":"Stanley","year":"1981","journal-title":"Cell"},{"key":"2025032410232519200_r5","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI113803","article-title":"Isolation of complementary DNA for bullous pemphigoid antigen by use of patients\u2019 autoantibodies","volume":"82","author":"Stanley","year":"1988","journal-title":"J. Clin. Invest."},{"key":"2025032410232519200_r6","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.136.4.1231","article-title":"Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting","volume":"136","author":"Labib","year":"1986","journal-title":"J. Immunol."},{"key":"2025032410232519200_r7","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1172\/JCI114812","article-title":"Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome","volume":"86","author":"Diaz","year":"1990","journal-title":"J. Clin. Invest."},{"key":"2025032410232519200_r8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0923-1811(99)00019-5","article-title":"Acquired skin disease of hemidesmosomes","volume":"20","author":"Zillikens","year":"1999","journal-title":"J. Dermatol. Sci."},{"key":"2025032410232519200_r9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/1523-1747.ep12337492","article-title":"Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies","volume":"109","author":"Zillikens","year":"1997","journal-title":"J. Invest. Dermatol."},{"key":"2025032410232519200_r10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch. Dermatol."},{"key":"2025032410232519200_r11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1046\/j.1523-1747.2002.01720.x","article-title":"Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin","volume":"118","author":"Sitaru","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"2025032410232519200_r12","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J. Clin. Invest."},{"key":"2025032410232519200_r13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.0022-202x.2001.01683.x","article-title":"Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid","volume":"118","author":"Yamamoto","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"2025032410232519200_r14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen","volume":"13","author":"Nishie","year":"2007","journal-title":"Nat. Med."},{"key":"2025032410232519200_r15","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1038\/sj.jid.5700970","article-title":"Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice","volume":"127","author":"Olasz","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"2025032410232519200_r16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.jid.5700681","article-title":"IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice","volume":"127","author":"Zone","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"2025032410232519200_r17","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/sj.jid.5700958","article-title":"A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu\/nu mice","volume":"127","author":"Fairley","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"2025032410232519200_r18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J. Autoimmun."},{"key":"2025032410232519200_r19","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.4049\/jimmunol.0800389","article-title":"A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodies","volume":"183","author":"Nishie","year":"2009","journal-title":"J. Immunol."},{"key":"2025032410232519200_r20","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.4049\/jimmunol.0903101","article-title":"A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen","volume":"184","author":"Ujiie","year":"2010","journal-title":"J. Immunol."},{"key":"2025032410232519200_r21","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI200521386","article-title":"Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen","volume":"115","author":"Sitaru","year":"2005","journal-title":"J. Clin. Invest."},{"key":"2025032410232519200_r22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/jid.2010.248","article-title":"Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita","volume":"131","author":"Ludwig","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"2025032410232519200_r23","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.4049\/jimmunol.165.10.5509","article-title":"Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma","volume":"165","author":"Denzler","year":"2000","journal-title":"J. Immunol."},{"key":"2025032410232519200_r24","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.4049\/jimmunol.177.5.3461","article-title":"Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice","volume":"177","author":"Sitaru","year":"2006","journal-title":"J. Immunol."},{"key":"2025032410232519200_r25","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1365-2133.2010.09680.x","article-title":"Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita","volume":"162","author":"Kasperkiewicz","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"2025032410232519200_r26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0738-081X(00)00178-4","article-title":"Electron microscopy in diagnosis of autoimmune bullous disorders","volume":"19","author":"Ishiko","year":"2001","journal-title":"Clin. Dermatol."},{"key":"2025032410232519200_r27","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1172\/JCI116368","article-title":"Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin","volume":"91","author":"Ishiko","year":"1993","journal-title":"J. Clin. Invest."},{"key":"2025032410232519200_r28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/1523-1747.ep12505711","article-title":"Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient","volume":"78","author":"Dvorak","year":"1982","journal-title":"J. Invest. Dermatol."},{"key":"2025032410232519200_r29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1523-1747.1998.00107.x","article-title":"Epitope spreading: lessons from autoimmune skin diseases","volume":"110","author":"Chan","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"2025032410232519200_r30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1523-1747.1999.00497.x","article-title":"IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180","volume":"112","author":"Perriard","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"2025032410232519200_r31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/1523-1747.ep12709613","article-title":"IgG subclasses of intercellular and basement membrane zone antibodies: the relationship to the capability of complement fixation","volume":"92","author":"Yamada","year":"1989","journal-title":"J. Invest. Dermatol."},{"key":"2025032410232519200_r32","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archderm.1974.01630090016003","article-title":"IgE levels in sera of patients with pemphigus or bullous pemphigoid","volume":"110","author":"Arbesman","year":"1974","journal-title":"Arch. Dermatol."},{"key":"2025032410232519200_r33","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1084\/jem.143.4.833","article-title":"Suppression of IgE antibody production in SJL mice. I. Nonspecific suppressor T cells","volume":"143","author":"Watanabe","year":"1976","journal-title":"J. Exp. Med."},{"key":"2025032410232519200_r34","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1073\/pnas.92.25.11931","article-title":"Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4","volume":"92","author":"Yoshimoto","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032410232519200_r35","first-page":"193","article-title":"Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin","volume":"18","author":"Provost","year":"1974","journal-title":"Clin. Exp. Immunol."},{"key":"2025032410232519200_r36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2133.1992.tb11833.x","article-title":"Serum IgE antibodies bind to the epidermal side of the basement membrane zone splits in bullous pemphigoid","volume":"126","author":"Parodi","year":"1992","journal-title":"Br. J. Dermatol."},{"key":"2025032410232519200_r37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1346-8138.2000.tb02141.x","article-title":"Polymorphisms of HLA-DR and -DQ genes in Japanese patients with bullous pemphigoid","volume":"27","author":"Okazaki","year":"2000","journal-title":"J. Dermatol."},{"key":"2025032410232519200_r38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00403-007-0755-8","article-title":"Relevance of the low-affinity type of the Fcgamma-receptor IIIa-polymorphism in bullous pemphigoid","volume":"299","author":"Weisenseel","year":"2007","journal-title":"Arch. Dermatol. Res."},{"key":"2025032410232519200_r39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaad.2009.09.010","article-title":"The role of Fc gamma receptors polymorphisms in bullous pemphigoid","volume":"63","author":"Guilabert","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"2025032410232519200_r40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1152\/physiolgenomics.00185.2007","article-title":"Genetic influence on immune phenotype revealed strain-specific variations in peripheral blood lineages","volume":"34","author":"Petkova","year":"2008","journal-title":"Physiol. Genomics"},{"key":"2025032410232519200_r41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jneuroim.2003.11.004","article-title":"Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis","volume":"146","author":"Palaszynski","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"2025032410232519200_r42","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.4049\/jimmunol.167.12.7094","article-title":"Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL\/J mice","volume":"167","author":"Du","year":"2001","journal-title":"J. Immunol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/187\/3\/1176\/62477035\/1100596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/187\/3\/1176\/62477035\/1100596.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T22:32:17Z","timestamp":1743114737000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/187\/3\/1176\/7973956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,1]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,8,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1100596","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,8]]},"published":{"date-parts":[[2011,8,1]]}}}